Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system.
Natalizumab versus fingolimod in patients with relapsing-remitting multiple sclerosis non-responding to first-line injectable therapies.
Ageing and recurrent episodes of neuroinflammation promote progressive eae in biozzi abh mice.
N98S mutation in NEFL gene is dominantly inherited with a phenotype of polyneuropathy and cerebellar atrophy.
Novel Insights into Acid-Sensing Ion Channels: Implications for Degenerative Diseases.
Alterations in brain white matter contributing to age-related slowing of task switching performance: The role of radial diffusivity and magnetization transfer ratio.
Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.
CADASIL mimicking multiple sclerosis: The importance of clinical and MRI red flags.
Extrapontine myelinolysis associated with severe hypernatremia in infancy.
CSF neurofilament light: A universal risk biomarker in multiple sclerosis?
Relationship of grey and white matter abnormalities with distance from the surface of the brain in multiple sclerosis.
Multiple sclerosis: Biomarkers and genetic variants reflect disease course in multiple sclerosis.
Ghrelin and adipose-derived mesenchymal stromal cells improve nerve regeneration in a rat model of epsilon-caprolactone conduit reconstruction.
Management of bladder dysfnction in patients with multiple sclerosis.
The Dress: Transforming a web viral event into a scientific survey.
Improved Automatic Detection of New T2 Lesions in Multiple Sclerosis Using Deformation Fields.
New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies.
Regional Myelin and Axon Damage and Neuroinflammation in the Adult Mouse Brain After Long-Term Postnatal Vanadium Exposure.
Acute Disseminated Encephalomyelitis After Influenza Vaccination: A Case Report.
Survey of US Patients with Multiple Sclerosis: Comparison of the New Electronic Interferon Beta-1b Autoinjector (BETACONNECT™) With Mechanical Autoinjectors.
Insulin influenced expression of myelin proteins in diabetic peripheral neuropathy.
Imaging of noninfectious inflammatory disorders of the spinal cord.
Vascular, glial, and lymphatic immune gateways of the central nervous system.
Polyomavirus detection in multiple sclerosis patients under natalizumab therapy: Profile and frequency of urinary shedding.
Pages
« first
‹ previous
…
844
845
846
847
848
849
850
851
852
…
next ›
last »